Search Results

You are looking at 1 - 1 of 1 items for :

  • radioiodine avidity restoration x
  • Thyroid cancer - basic and translational x
Clear All
Abdul Rehman Syed University of Calgary, Calgary, Alberta, Canada

Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Close
,
Aakash Gorana Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada

Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Close
,
Erik Nohr Alberta Precision Laboratories, Molecular Pathology Program, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Erik Nohr in
Google Scholar
PubMed
Close
,
Xiaoli-Kat Yuan Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Close
,
Parthiv Amin MASc Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada

Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Close
,
Sana Ghaznavi Arnie Charbonneau Cancer Institute, Department of Medicine, Section of Endocrinology, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Close
,
Debbie Lamb Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada

Search for other papers by Debbie Lamb in
Google Scholar
PubMed
Close
,
John McIntyre Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by John McIntyre in
Google Scholar
PubMed
Close
,
Markus Eszlinger Department of Oncology, Cumming School of Medicine, and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Close
, and
Ralf Paschke Departments of Medicine, Section of Endocrinology, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

significant uptake, confirming restoration of RAI-avidity (post- 131 I treatment WBS, Fig. 3 ). In addition, a chest CT conducted in May 2022 (1 month before larotrectinib treatment) visualized target lesion 1 measured at 8 × 6 mm, while the target lesion 2

Open access